Alaska Prescription Drug Monitoring Program



Similar documents
Delaware. Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency

11/26/2012. Implementation of Florida s PDMP. Disclosure

Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy

New Jersey. Contact Information. Statistics. Technological Capabilities

CURES Prescription Drug Monitoring Program

PDMP User s Guide. Oregon Health Authority Prescription Drug Monitoring Program

Maryland. Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration Substance Abuse Agency

Implementation of Florida s PDMP. Rebecca Poston Program Manager

Training Guide for Florida Practitioners and Pharmacists

Washington. Contact Information. Statistics. Technological Capabilities

Georgia. Contact Information. Office: Fax: Statistics. Technological Capabilities

South Dakota Prescription Drug Monitoring Program (SD PDMP) Learning Objectives

Massachusetts. Contact Information. Statistics. Technological Capabilities

Training Guide for Delaware Practitioners and Pharmacists Delaware Division of Professional Regulation Prescription Monitoring Program

Prescription Drug Monitoring Program Annual Report

Idaho. Contact Information. Fax: (208) Statistics. Technological Capabilities

Dispenser s Implementation Guide

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015

Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting 9/23/2014

Illinois. Contact Information. Office: Fax: Statistics. Technological Capabilities

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA

Training Guide for Government Agencies and Healthcare Administration

MEDICAL ASSISTANCE BULLETIN

Guam. Contact Information. Statistics. Technological Capabilities

State Prescription Monitoring Program (SPMP) Patch PSO*7*408. Release Notes

Subject: Health; prescription drugs; Vermont Prescription Monitoring 5 System

2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS

Prescription Drug Monitoring Program. A Powerful Tool

Health Professions Act BYLAWS SCHEDULE F. PART 3 Residential Care Facilities and Homes Standards of Practice. Table of Contents

Oregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority:

EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: January 2016

Pharmacy Operations. Assisting the Pharmacist. Pharmacy Technician Training Systems Passassured, LLC

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES

For a Healthier America: Reducing Prescription Drug Misuse and Abuse

PRESCRIPTION MONITORING PROGRAM (PMP)

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES

CHAPTER Section 34 of P.L.1970, c.226 (C.24:21-34) is amended to read as follows:

PLEASE READ. The official text of New Jersey Statutes can be found through the home page of the New Jersey Legislature

Maryland Prescription Drug Monitoring Program (PDMP) Hospice Inpatient Waiver Application

Controlled Substances Prescription Monitoring Program. Dean Wright, RPh Arizona State Board of Pharmacy

Manual of Instructions

NOTICES OF PROPOSED RULEMAKING

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR. 1) Health Care Mitchell Collins 2) 3) 4) 5)

Technical Assistance Guide. PDMP Suggested Practices to Ensure Pharmacy Compliance and Improve Data Integrity

Michael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy

PHARMACY TECHNICIAN LICENSURE S.B. 92: ANALYSIS AS ENACTED

House Study Bill Introduced

K-TRACS KANSAS TRACKING AND REPORTING OF CONTROLLED SUBSTANCES

ANALYSIS AS REPORTED FROM COMMITTEE

AMERICAN PSYCHOLOGICAL ASSOCIATION

Pharmacy Operating Guidelines & Information

Prescription Drug Monitoring Program Center of Excellence at Brandeis

NH Laws / Rules Regarding Limited Retail Drug Distributors

State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations

IAC 10/5/11 Pharmacy[657] Ch 40, p.1 CHAPTER 40 TECH-CHECK-TECH PROGRAMS

Prescribers required to check PDMP before first prescription for Controled Substances for new patient.

SCOPE OF PRACTICE FOR ARNPS

Virginia Telemedicine Law: 17th Annual Virginia Health Law Legislative Update

GRANT REQUEST FOR PROPOSAL. Issued By. Minnesota Board of Pharmacy

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act.

Prescription Monitoring Programs: Creating a National Network

11 Contacts for Health Care Practitioners & Providers

PROPOSED REGULATION OF THE STATE BOARD OF PHARMACY. LCB File No. R September 15, 2015

STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council

Prescription Drug Monitoring Programs Bill Status Update

American Indian Health Commission for Washington State October 1, 2015

REGISTERED NURSE ANESTHETIST APPLICATION

FREQUENTLY ASKED QUESTIONS

Prescribing Standards for Nurse Practitioners (NPs)

Electronic Prescribing In New York State

How to Utilize the Security Portal to Access PDMP (User Guide for Practitioners, Pharmacists, CRNPs, Physician Assistants, Law Enforcement, and CNMs)

Electronic Prescribing of Controlled Substances

3.Prescriber DEA: 4.Board Registration Number: 5.Business Tel:

Massachusetts Department of Public Health (MDPH) Prescription Monitoring Program (MA PMP) and Drug Control Program (DCP) April 8, 2014

May a company designate any of this information as trade secret?

Transcription:

Alaska 1. What is a PDMP? PDMP stands for. This is a commonly used term for the programs implemented by various states to monitor the dispensing of controlled substances within their borders. For this purpose, Schedule II through V drugs are typically considered controlled. From a dispenser standpoint, the legal requirement to submit data for use in a state s PDMP program is sometimes called Controlled Substance Reporting. 2. What is the Alaska PDMP? The Alaska is Alaska s solution for monitoring Schedule II-V controlled substances dispensed in Alaska. Senate Bill 196 (Alaska Statute 08.80.030(b)(11)), signed into law on September 7, 2008, requires the Board of Pharmacy to establish and maintain a controlled substances prescription database as provided in AS 17.30.300 for the reporting of dispensed prescriptions for all Schedule IA VA controlled substances under state law and Schedule II V controlled substances under federal law. The solution has two main components: Data Submission: Information about controlled substance dispensing activities is regularly reported to the state of Alaska through their authorized data collection vendor. Pharmacies and other dispensers (clinics, etc.) that are licensed by the Alaska Board of Pharmacy are required by law to provide such reporting to the data collection vendor in approved formats and frequencies. This includes mail order pharmacies that routinely mail orders into the state. Report Retrieval: Alaska s online reporting application allows authorized users to generate customized reports 24 hours a day, seven days a week. A report shows information for all the scheduled prescriptions a specified patient has had for a specified period. An authorized user can be a prescriber for medical treatment of an existing or prospective patient; a pharmacist for pharmaceutical treatment; a law enforcement officer with an active investigation; a licensure board for a licensee; a grand jury by subpoena; or a judge, probation, or parole officer administering a drug diversion or probation program. The primary beneficiaries of the Alaska PDMP are patients throughout Alaska. Because of the Alaska PDMP, healthcare providers can make better and more informed treatment decisions that allow them to provide the most appropriate medical care for their patients. However, all Alaska citizens ultimately benefit through improved medical care and reductions in the abuse and diversion of controlled substance prescription drugs. Copyright 2013 Health Information Designs, LLC 1

3. Who is HID? Alaska s Board of Pharmacy (Board) has selected Health Information Designs, LLC (HID) to develop a database that will collect and store prescribing and dispensing data for Schedules II-V controlled substances and any other drugs specified by Alaska law as amended. HID s RxSentry is a Web-based program that facilitates the collection, analysis, and reporting of information on the prescribing, dispensing, and use of controlled substance prescription drugs. HID stands out in the healthcare analytics industry as the leader in providing innovative, forward-thinking PDMP projects combining state-of-the-art Web-based software tools and professional, responsive customer service. By listening closely, customizing our solutions to meet specific needs and requirements, and managing each project with client satisfaction as our first priority, we continue to extend and build new client partnerships. 4. What does it do? The Alaska PDMP is a centralized database that holds controlled substance prescription information for all patients across the state. Dispensers will submit data to the database. Prescribers will be able to review prescription history information and look for potential interactions. It will protect patient safety and deter prescription drug misuse. 5. What data submission format will I use? Alaska is using ASAP 4.1 (2009). If you have any questions, contact your pharmacy vendor, or you may contact HID s PDMP Help Desk by e-mail at akpdmpinfo@hidinc.com or by phone at (855) 263-6404. For more information regarding ASAP 4.1 specifications, contact the American Society for Automation in Pharmacy at www.asapnet.org for the full Implementation Guide for the ASAP Standard for Prescription-Monitoring Programs. This guide includes field lengths, acceptable attributes, and examples. 6. What prescription information is collected? Information submitted to the database will include the following: Patient name, address, and date of birth Prescriber and dispenser information Drug name and dosage; the prescribing and dispensing dates Method of payment Copyright 2013 Health Information Designs, LLC 2

7. How much will your data collection services cost? The PDMP data collection services we provide to you are paid by Alaska. We do not charge you anything for these services, regardless of your submission method. 8. How often am I required to report? 12 AAC 52.865 states, A dispenser must provide the information required by transmitting to the board or the board s agent no later than the fifth of the following month for all prescriptions dispensed on and between the first day and the last day of the previous month. This means that each time a controlled substance is dispensed to an individual, the controlled substance must be reported to the AK PDMP, using a format approved by the Alaska Board of Pharmacy, once per month but no later than the fifth (5 th ) day of the following month. Beginning March 15, 2013, dispensers will begin submitting their data to HID. Therefore, data for the month of March must be reported to HID by April 5, 2013. However, dispensers are encouraged to report more frequently if they would like. 9. Do I need to sign up or just start submitting data? You will need to register with HID through a simple process in which you will verify basic information about your facility and indicate the submission method you will be using. This registration step also enhances the security of the submission process. If you were already registered for the Alaska PDMP through the previous vendor, RelayHealth, HID already has the information you provided when you initially registered. You will, however, need to verify that the information we have on file for you is correct and establish a new password to access HID s RxSentry system. For more information about the registration process, please see the RxSentry Dispenser s Implementation Guide or the RxSentry Training Guide for Alaska Practitioners and Pharmacists, depending on your user type. Both documents can be found on the Alaska PDMP website at www.alaskapdmp.com. Copyright 2013 Health Information Designs, LLC 3

10. Will I receive a submissions report? Yes. You will receive your report monthly via the method specified when you created your account, either e-mail or fax. If you FTP/SFTP the data, a report will be placed in your home directory on the FTP server. 11. What if my system vendor (or chain) sets up these kinds of things for me? We will gladly work with your vendor (or chain) to assist them with the setup process if they are able to support this option. Call our PDMP Help Desk with your vendor s contact information or provide your pharmacy system vendor with our support information. 12. Will I be able to pull a patient report? Yes, you can view the prescription history for a specified period for an individual patient. You may query any recipient who is a current or prospective patient, but before you can view the results of the query, you must authenticate the query by indicating the query is for a valid reason and that you have the potential to provide a service to the recipient who is being queried. 13. Which practitioners can access data? Physicians, pharmacists, dentists, physician assistants, nurse practitioners, veterinarians, and other licensed clinicians and professionals. 14. Will there be user guides? Yes, there will be user guides for data collection and reporting. Both guides will be available on the Alaska PDMP website, www.alaskapdmp.com. 15. Where can I go for more information? All updated information is posted on the Alaska PDMP website at www.alaskapdmp.com. Copyright 2013 Health Information Designs, LLC 4

16. Do other states have a similar program? Currently, 48 states have laws that authorize the establishment and operation of a PDMP. Thirty-six of these states programs are up and running. You can find more information on these programs on the Alliance of States with Prescription Monitoring Programs website, www.pmpalliance.org. Copyright 2013 Health Information Designs, LLC 5